Literature DB >> 33481806

Gastrointestinal disseminated histoplasmosis in HIV-infected patients: A descriptive and comparative study.

Mathieu Nacher1,2, Audrey Valdes3, Antoine Adenis1,2, Romain Blaizot2,4, Philippe Abboud5, Magalie Demar6,7, Félix Djossou5, Loïc Epelboin5, Caroline Misslin8, Balthazar Ntab9, Dominique Louvel10, Kinan Drak Alsibai11, Pierre Couppié2,4.   

Abstract

Disseminated histoplasmosis is one the main AIDS-defining opportunistic infections in HIV-infected patients, notably in Latin America. The non-specific and proteiform clinical presentation leads to diagnostic delays that may lead to fatal outcomes. This retrospective multicentric study aimed to describe the frequency and manifestations of gastrointestinal histoplasmosis in French Guiana, and to compare patients with disseminated histoplasmosis with or without gastrointestinal involvement. Between January 1, 1981 and October 1, 2014 co-infections with HIV and histoplasmosis were enrolled. Inclusion criteria were: age >18 years, confirmed HIV infection; first proven episode of histoplasmosis. Among 349 cases of disseminated histoplasmosis, 245 (70%) had a gastrointestinal presentation. Half of patients with gastrointestinal signs had abdominal pain or diarrhea, mostly watery. Half of patients with abdominal pain had diarrhea (63/124) and half of those with diarrhea (63/123) had abdominal pain. A significant proportion of patients also had hepatomegaly and, to a lesser degree, splenomegaly. After adjusting for potential confounding, the presence of lymphadenopathies >2cm (AOR = 0.2, IC95 = 0.04-0.7, P = 0.01), Haitian origin (AOR = 0.04, IC95 = 0.004-0.4, P = 0.006) were associated with a lower prevalence of gastrointestinal signs and positive gastrointestinal presence of H. capsulatum. Persons with a gastrointestinal H. capsulatum were more likely to have a decreased prothrombin time, lower ferritin, lower liver enzymes, and lower concentrations of LDH than those without gastrointestinal signs and symptoms. They also had a shorter interval between symptoms onset and diagnosis. Patients with a positive gastrointestinal identification of H. capsulatum were less likely to die at 1 month than those without a gastrointestinal presentation (respectively, 4.6% vs 18.5%, P = 0.01). Subacute or chronic gastrointestinal presentations are very frequent during disseminated histoplasmosis, they seem less severe, and should lead to suspect the diagnosis in endemic areas. There were populational or geographic differences in the frequency of gastrointestinal manifestations that could not be explained.

Entities:  

Mesh:

Year:  2021        PMID: 33481806      PMCID: PMC7857560          DOI: 10.1371/journal.pntd.0009050

Source DB:  PubMed          Journal:  PLoS Negl Trop Dis        ISSN: 1935-2727


  17 in total

1.  HIV-associated disseminated histoplasmosis in western French Guiana, 2002-2012.

Authors:  A Putot; S Perrin; A Jolivet; V Vantilcke
Journal:  Mycoses       Date:  2015-01-15       Impact factor: 4.377

2.  Tuberculosis and histoplasmosis among human immunodeficiency virus-infected patients: a comparative study.

Authors:  Antoine Adenis; Mathieu Nacher; Matthieu Hanf; Célia Basurko; Julie Dufour; Florence Huber; Christine Aznar; Bernard Carme; Pierre Couppie
Journal:  Am J Trop Med Hyg       Date:  2014-01-06       Impact factor: 2.345

3.  Morphological changes in the digestive system of 93 human immunodeficiency virus positive patients: an autopsy study.

Authors:  Lucinda Calheiros Guimarães; Ana Cristina Araujo Lemos Silva; Adilha Misson Rua Micheletti; Everton Nunes Melo Moura; Mario Leon Silva-Vergara; Sheila Jorge Adad
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2012 Mar-Apr       Impact factor: 1.846

4.  AIDS-related Histoplasma capsulatum var. capsulatum infection: 25 years experience of French Guiana.

Authors:  Florence Huber; Matthieu Nacher; Christine Aznar; Magalie Pierre-Demar; Myriam El Guedj; Tania Vaz; Vincent Vantilcke; Abba Mahamat; Christian Magnien; Elodie Chauvet; Bernard Carme; Pierre Couppié
Journal:  AIDS       Date:  2008-05-31       Impact factor: 4.177

5.  [Digestive histoplasmosis in a patient with AIDS from Guadeloupe].

Authors:  F Boulard; F Cnudde; B Teron-Aboud; P Kermanac'h; M Nicolas; B Juminer
Journal:  Ann Gastroenterol Hepatol (Paris)       Date:  1994 May-Jun

6.  Disseminated Histoplasmosis: A Challenging Differential Diagnostic Consideration for Suspected Malignant Lesions in the Digestive Tract.

Authors:  Bernhard Doleschal; Therese Rödhammer; Oleksiy Tsybrovskyy; Karl J Aichberger; Franz Lang
Journal:  Case Rep Gastroenterol       Date:  2016-11-07

7.  The Fight against HIV-Associated Disseminated Histoplasmosis in the Americas: Unfolding the Different Stories of Four Centers.

Authors:  Mathieu Nacher; Terezinha Silva Leitao; Beatriz L Gómez; Pierre Couppié; Antoine Adenis; Lisandra Damasceno; Magalie Demar; Blanca Samayoa; Diego H Cáceres; Roger Pradinaud; Anastacio de Queiroz Sousa; Eduardo Arathoon; Angela Restrepo
Journal:  J Fungi (Basel)       Date:  2019-06-17

Review 8.  The Broad Clinical Spectrum of Disseminated Histoplasmosis in HIV-Infected Patients: A 30 Years' Experience in French Guiana.

Authors:  Pierre Couppié; Katarina Herceg; Morgane Bourne-Watrin; Vincent Thomas; Denis Blanchet; Kinan Drak Alsibai; Dominique Louvel; Felix Djossou; Magalie Demar; Romain Blaizot; Antoine Adenis
Journal:  J Fungi (Basel)       Date:  2019-12-13

9.  Temporal trends of cutaneo-mucous histoplasmosis in persons living with HIV in French Guiana: Early diagnosis defuses South American strain dermotropism.

Authors:  Sophie Morote; Mathieu Nacher; Romain Blaizot; Balthazar Ntab; Denis Blanchet; Kinan Drak Alsibai; Magalie Demar; Félix Djossou; Pierre Couppié; Antoine Adenis
Journal:  PLoS Negl Trop Dis       Date:  2020-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.